NewsBenzingaSS 이노베이션스 인터내셔널, SSi 만트라 외과용 로봇 시스템 제출 관련 FDA의 추가 정보 요청 서한에 대한 답변서 제출 SS 이노베이션스 인터내셔널, SSi 만트라 외과용 로봇 시스템 제출 관련 FDA의 추가 정보 요청 서한에 대한 답변서 제출 Benzinga 2026.10.13 12:34 (GMT+0) Open on Benzinga Other news 'China Taps US AI Models To Train Homegrown Rivals As Chip Curbs Bite' - Reuters Exclusive 'US Presses UN Agency Over Taiwan Flight Restrictions, China Hits Back' - Reuters Exclusive 'Ruined The System'? Pete Buttigieg Pushes Back On Trump's FAA Blame, Demands Accounting for Billions In Modernization Funds After 'Worst FAA Communications Breakdown This Century' Reported Earlier, NextNRG Q3 EPS $(6.88) Misses $(6.00) Estimate, Sales $26.715M Miss $28.087M Estimate Reported Earlier, Lecanemab Five-Year Clarity AD Data: 36% Lower Relative Risk Of Disease-Stage Progression Vs. ADNI, 62% Of Low-Tau Patients Improved On CDR-SB, Consistent Safety Profile, Per Eisai And Biogen Aytu BioPharma Stock Climbs 44% After-Hours: Here's Why
'Ruined The System'? Pete Buttigieg Pushes Back On Trump's FAA Blame, Demands Accounting for Billions In Modernization Funds After 'Worst FAA Communications Breakdown This Century'
Reported Earlier, NextNRG Q3 EPS $(6.88) Misses $(6.00) Estimate, Sales $26.715M Miss $28.087M Estimate
Reported Earlier, Lecanemab Five-Year Clarity AD Data: 36% Lower Relative Risk Of Disease-Stage Progression Vs. ADNI, 62% Of Low-Tau Patients Improved On CDR-SB, Consistent Safety Profile, Per Eisai And Biogen